| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.749 | 0.005 | 0.749 | Aldehyde oxidase inhibitor | 0.72 0.007 CID_66 | ||
| 0.714 | 0.006 | 0.714 | 5 Hydroxytryptamine release stimulant | 0.57 0.018 CID_66 | ||
| 0.692 | 0.003 | 0.692 | GABA C receptor rho-3 antagonist | 0.63 0.005 CID_66 | ||
| 0.619 | 0.009 | 0.619 | 5 Hydroxytryptamine release inhibitor | 0.53 0.024 CID_66 | ||
| 0.56 | 0.003 | 0.56 | 5 Hydroxytryptamine uptake stimulant | 0.543 0.004 CID_66 | ||
| 0.561 | 0.026 | 0.561 | Antiobesity | 0.333 0.096 CID_66 | ||
| 0.555 | 0.024 | 0.555 | Cholesterol antagonist | 0.477 0.036 CID_66 | ||
| 0.542 | 0.018 | 0.542 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.394 0.106 CID_66 | ||
| 0.523 | 0.008 | 0.651 | Peroxidase inhibitor | 0.651 0.004 CID_66 | CID_66 | |
| 0.512 | 0.005 | 0.512 | Alpha-N-acetylglucosaminidase inhibitor | 0.375 0.01 CID_66 | ||
| 0.536 | 0.048 | 0.536 | Caspase 9 stimulant | 0.447 0.084 CID_66 | ||
| 0.477 | 0.038 | 0.477 | Histamine release inhibitor | 0.42 0.065 CID_66 | ||
| 0.45 | 0.011 | 0.45 | Calcium channel activator | 0.396 0.026 CID_66 | ||
| 0.44 | 0.004 | 0.472 | Succinate dehydrogenase inhibitor | 0.472 0.003 CID_66 | CID_66 | |
| 0.432 | 0.003 | 0.432 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.387 0.004 CID_66 | ||
| 0.428 | 0.005 | 0.428 | GABA C receptor agonist | 0.327 0.008 CID_66 | ||
| 0.429 | 0.022 | 0.429 | Superoxide dismutase inhibitor | 0.343 0.038 CID_66 | ||
| 0.417 | 0.014 | 0.417 | Anesthetic general | 0.318 0.029 CID_66 | ||
| 0.399 | 0.004 | 0.399 | Ferrochelatase inhibitor | 0.246 0.014 CID_66 | ||
| 0.385 | 0.004 | 0.385 | Potassium channel large-conductance Ca-activated activator | 0.27 0.005 CID_66 | ||
| 0.446 | 0.066 | 0.446 | Analgesic | 0.308 0.136 CID_66 | ||
| 0.388 | 0.009 | 0.388 | Tyrosine 3 hydroxylase inhibitor | 0.366 0.013 CID_66 | ||
| 0.383 | 0.005 | 0.587 | Cystathionine beta-synthase inhibitor | 0.587 0.003 CID_66 | CID_66 | |
| 0.396 | 0.018 | 0.396 | RNA-directed DNA polymerase inhibitor | 0.367 0.022 CID_66 | ||
| 0.393 | 0.039 | 0.393 | Aryl hydrocarbon receptor agonist | 0.236 0.085 CID_66 | ||
| 0.344 | 0.005 | 0.344 | Nitric-oxide synthase stimulant | 0.304 0.01 CID_66 | ||
| 0.334 | 0.006 | 0.334 | NADH dehydrogenase inhibitor | 0.333 0.006 CID_66 | ||
| 0.377 | 0.054 | 0.377 | Streptokinase A inhibitor | 0.3 0.079 CID_66 | ||
| 0.327 | 0.004 | 0.327 | GABA C receptor rho-2 antagonist | 0.24 0.014 CID_66 | ||
| 0.389 | 0.067 | 0.389 | Calpain 2 inhibitor | 0.293 0.119 CID_66 | ||
| 0.345 | 0.023 | 0.345 | ErbB-1 antagonist | 0.234 0.06 CID_66 | ||
| 0.326 | 0.007 | 0.326 | 3C-like protease (Human coronavirus) inhibitor | 0.269 0.02 CID_66 | ||
| 0.32 | 0.004 | 0.32 | Electrolyte absorption antagonist | 0.24 0.005 CID_66 | ||
| 0.321 | 0.009 | 0.39 | UDP-glucose 4-epimerase inhibitor | 0.39 0.006 CID_66 | CID_66 | |
| 0.323 | 0.018 | 0.323 | 5 Hydroxytryptamine 1E antagonist | 0.28 0.045 CID_66 | ||
| 0.35 | 0.05 | 0.35 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.305 0.063 CID_66 | ||
| 0.334 | 0.035 | 0.334 | Psychostimulant | 0.208 0.076 CID_66 | ||
| 0.303 | 0.005 | 0.303 | 5 Hydroxytryptamine 3E antagonist | 0.218 0.038 CID_66 | ||
| 0.295 | 0.004 | 0.295 | GABA C receptor antagonist | 0.212 0.011 CID_66 | ||
| 0.292 | 0.006 | 0.311 | Mannose-6-phosphate isomerase inhibitor | 0.311 0.005 CID_66 | CID_66 | |
| 0.311 | 0.026 | 0.311 | Gastrin inhibitor | 0.222 0.116 CID_66 | ||
| 0.288 | 0.004 | 0.288 | 5 Hydroxytryptamine 3A agonist | 0.213 0.012 CID_66 | ||
| 0.298 | 0.019 | 0.298 | Neurotrophic factor enhancer | 0.277 0.025 CID_66 | ||
| 0.318 | 0.04 | 0.318 | Interleukin agonist | 0.237 0.088 CID_66 | ||
| 0.28 | 0.004 | 0.283 | Creatine kinase inhibitor | 0.283 0.004 CID_66 | CID_66 | |
| 0.292 | 0.019 | 0.304 | Amylase inhibitor | 0.304 0.018 CID_66 | CID_66 | |
| 0.29 | 0.02 | 0.29 | Amyloid beta precursor protein antagonist | 0.213 0.05 CID_66 | ||
| 0.279 | 0.008 | 0.279 | ATPase inhibitor | 0.246 0.014 CID_66 | ||
| 0.275 | 0.016 | 0.275 | NADPH oxidase inhibitor | 0.225 0.027 CID_66 | ||
| 0.269 | 0.013 | 0.269 | Glutamate receptor antagonist | 0.116 0.078 CID_66 | ||
| 0.323 | 0.068 | 0.39 | 12-Lipoxygenase inhibitor | 0.39 0.042 CID_66 | CID_66 | |
| 0.262 | 0.007 | 0.296 | Potassium channel (Ca-activated) activator | 0.296 0.005 CID_66 | CID_66 | |
| 0.283 | 0.029 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.271 0.034 CID_66 | ||
| 0.264 | 0.01 | 0.264 | Chemokine receptor antagonist | 0.138 0.037 CID_66 | ||
| 0.256 | 0.004 | 0.256 | Glutamate release inhibitor | 0.194 0.005 CID_66 | ||
| 0.251 | 0.005 | 0.251 | HIV-1 integrase (Overall Integration) inhibitor | 0.248 0.005 CID_66 | ||
| 0.252 | 0.007 | 0.252 | Triose-phosphate isomerase inhibitor | 0.177 0.014 CID_66 | ||
| 0.249 | 0.005 | 0.249 | Prostaglandin E2 antagonist | 0.046 0.039 CID_66 | ||
| 0.26 | 0.016 | 0.26 | Aldehyde dehydrogenase inhibitor | 0.233 0.021 CID_66 | ||
| 0.248 | 0.005 | 0.248 | Dopamine D4 agonist | 0.051 0.034 CID_66 | ||
| 0.29 | 0.047 | 0.32 | DNA synthesis inhibitor | 0.32 0.037 CID_66 | CID_66 | |
| 0.276 | 0.034 | 0.276 | Neuropeptide Y2 antagonist | 0.231 0.075 CID_66 | ||
| 0.314 | 0.076 | 0.314 | Vasodilator, coronary | 0.226 0.158 CID_66 | ||
| 0.295 | 0.059 | 0.36 | Transcription factor STAT inhibitor | 0.36 0.03 CID_66 | CID_66 | |
| 0.241 | 0.005 | 0.241 | GABA C receptor rho-1 antagonist | 0.164 0.016 CID_66 | ||
| 0.296 | 0.061 | 0.296 | Insulysin inhibitor | 0.268 0.081 CID_66 | ||
| 0.266 | 0.037 | 0.266 | Non-steroidal antiinflammatory agent | 0.201 0.07 CID_66 | ||
| 0.287 | 0.06 | 0.287 | Transcription factor STAT3 inhibitor | 0.281 0.063 CID_66 | ||
| 0.235 | 0.009 | 0.236 | Arachidonic acid antagonist | 0.236 0.009 CID_66 | CID_66 | |
| 0.315 | 0.089 | 0.315 | Vasodilator, peripheral | 0.241 0.134 CID_66 | ||
| 0.241 | 0.019 | 0.241 | Cholesterol synthesis inhibitor | 0.2 0.027 CID_66 | ||
| 0.226 | 0.004 | 0.226 | Lanosterol 14 alpha demethylase inhibitor | 0.16 0.008 CID_66 | ||
| 0.274 | 0.053 | 0.274 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.138 CID_66 | ||
| 0.231 | 0.01 | 0.279 | Histidine decarboxylase inhibitor | 0.279 0.007 CID_66 | CID_66 | |
| 0.239 | 0.019 | 0.239 | Hexokinase inhibitor | 0.194 0.039 CID_66 | ||
| 0.231 | 0.014 | 0.231 | Carbonic anhydrase XV inhibitor | 0.173 0.024 CID_66 | ||
| 0.225 | 0.012 | 0.225 | Cyclooxygenase 3 inhibitor | 0.188 0.024 CID_66 | ||
| 0.218 | 0.006 | 0.218 | Sphingosine 1-phosphate receptor 4 antagonist | 0.172 0.018 CID_66 | ||
| 0.22 | 0.009 | 0.22 | CC chemokine receptor antagonist | 0.107 0.031 CID_66 | ||
| 0.237 | 0.028 | 0.315 | Phospholipase C inhibitor | 0.315 0.017 CID_66 | CID_66 | |
| 0.225 | 0.018 | 0.225 | Catenin beta inhibitor | 0.179 0.054 CID_66 | ||
| 0.215 | 0.01 | 0.215 | Porphobilinogen synthase inhibitor | 0.197 0.012 CID_66 | ||
| 0.216 | 0.014 | 0.216 | CF transmembrane conductance regulator agonist | 0.186 0.031 CID_66 | ||
| 0.208 | 0.006 | 0.208 | Purinergic P2 antagonist | |||
| 0.253 | 0.052 | 0.253 | MAP kinase kinase 2 inhibitor | 0.152 0.119 CID_66 | ||
| 0.222 | 0.022 | 0.235 | Cell wall synthesis inhibitor | 0.235 0.019 CID_66 | CID_66 | |
| 0.201 | 0.003 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.191 0.004 CID_66 | ||
| 0.204 | 0.006 | 0.204 | Alcohol oxidase inhibitor | 0.178 0.008 CID_66 | ||
| 0.207 | 0.009 | 0.207 | Pregnane X receptor agonist | 0.166 0.03 CID_66 | ||
| 0.21 | 0.014 | 0.21 | Adenylate kinase inhibitor | 0.156 0.024 CID_66 | ||
| 0.245 | 0.05 | 0.245 | Sigma receptor agonist | |||
| 0.316 | 0.121 | 0.316 | 15-Lipoxygenase inhibitor | 0.305 0.129 CID_66 | ||
| 0.199 | 0.007 | 0.2 | DOPA decarboxylase inhibitor | 0.2 0.007 CID_66 | CID_66 | |
| 0.227 | 0.035 | 0.227 | Diuretic | 0.208 0.041 CID_66 | ||
| 0.211 | 0.02 | 0.211 | Cathepsin H inhibitor | 0.143 0.051 CID_66 | ||
| 0.219 | 0.028 | 0.228 | M18 aspartyl aminopeptidase inhibitor | 0.228 0.026 CID_66 | CID_66 | |
| 0.224 | 0.034 | 0.229 | Interferon gamma antagonist | 0.229 0.033 CID_66 | CID_66 | |
| 0.252 | 0.063 | 0.252 | Calpain inhibitor | 0.229 0.085 CID_66 | ||
| 0.197 | 0.008 | 0.197 | CYP2A6 inhibitor | 0.088 0.042 CID_66 | ||
| 0.199 | 0.012 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | 0.193 0.015 CID_66 | ||
| 0.245 | 0.059 | 0.245 | Anticonvulsant | |||
| 0.195 | 0.009 | 0.195 | Sphingosine 1-phosphate receptor 2 antagonist | 0.195 0.009 CID_66 | ||
| 0.223 | 0.037 | 0.223 | Cytidine deaminase inhibitor | 0.128 0.093 CID_66 | ||
| 0.201 | 0.016 | 0.201 | Carbonic anhydrase III inhibitor | 0.174 0.021 CID_66 | ||
| 0.283 | 0.1 | 0.283 | Antithrombotic | 0.221 0.152 CID_66 | ||
| 0.197 | 0.014 | 0.197 | Interleukin 8 antagonist | 0.183 0.018 CID_66 | ||
| 0.189 | 0.006 | 0.189 | Adrenaline uptake inhibitor | 0.082 0.026 CID_66 | ||
| 0.194 | 0.012 | 0.194 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.196 | 0.015 | 0.196 | Adenylate cyclase stimulant | 0.188 0.02 CID_66 | ||
| 0.196 | 0.016 | 0.196 | Catalase inhibitor | 0.136 0.029 CID_66 | ||
| 0.21 | 0.03 | 0.21 | Neurotensin receptor agonist | 0.193 0.039 CID_66 | ||
| 0.214 | 0.036 | 0.214 | Cyclooxygenase inhibitor | 0.169 0.057 CID_66 | ||
| 0.281 | 0.106 | 0.311 | Transcription factor NF kappa B inhibitor | 0.311 0.089 CID_66 | CID_66 | |
| 0.187 | 0.013 | 0.187 | Sphingomyelinase inhibitor | 0.168 0.018 CID_66 | ||
| 0.179 | 0.005 | 0.179 | NMDA receptor agonist | 0.121 0.013 CID_66 | ||
| 0.188 | 0.015 | 0.188 | DNA directed RNA polymerase inhibitor | 0.187 0.016 CID_66 | ||
| 0.182 | 0.01 | 0.182 | Cannabinoid receptor antagonist | 0.081 0.039 CID_66 | ||
| 0.176 | 0.005 | 0.176 | Bromodomain-containing protein 2 inhibitor | 0.115 0.027 CID_66 | ||
| 0.205 | 0.033 | 0.205 | Nav1.2 sodium channel blocker | 0.126 0.076 CID_66 | ||
| 0.236 | 0.065 | 0.243 | Pyruvate kinase inhibitor | 0.243 0.063 CID_66 | CID_66 | |
| 0.175 | 0.005 | 0.175 | Purinergic P2X antagonist | |||
| 0.174 | 0.005 | 0.174 | Sphingosine 1-phosphate receptor 4 agonist | 0.172 0.005 CID_66 | ||
| 0.211 | 0.042 | 0.211 | Antipruritic | 0.191 0.055 CID_66 | ||
| 0.18 | 0.012 | 0.18 | Heat shock protein 70 antagonist | 0.16 0.028 CID_66 | ||
| 0.173 | 0.005 | 0.173 | GABA aminotransferase inhibitor | 0.164 0.006 CID_66 | ||
| 0.176 | 0.009 | 0.176 | Phenylalanine 4-hydroxylase inhibitor | 0.168 0.009 CID_66 | ||
| 0.193 | 0.027 | 0.193 | MAP kinase 3 inhibitor | 0.151 0.066 CID_66 | ||
| 0.169 | 0.005 | 0.169 | Glycine receptor antagonist | 0.135 0.012 CID_66 | ||
| 0.173 | 0.008 | 0.173 | Histamine N-methyltransferase inhibitor | 0.125 0.027 CID_66 | ||
| 0.169 | 0.005 | 0.169 | Glycine receptor agonist | 0.142 0.008 CID_66 | ||
| 0.197 | 0.034 | 0.197 | Alkaline phosphatase inhibitor | 0.197 0.034 CID_66 | ||
| 0.165 | 0.003 | 0.165 | Exportin-1 inhibitor | 0.119 0.005 CID_66 | ||
| 0.178 | 0.016 | 0.178 | TRPA1 agonist | 0.137 0.041 CID_66 | ||
| 0.193 | 0.032 | 0.193 | Sodium channel (voltage-gated) blocker | 0.142 0.06 CID_66 | ||
| 0.167 | 0.006 | 0.167 | Cannabinoid CB1 receptor antagonist | 0.073 0.032 CID_66 | ||
| 0.206 | 0.046 | 0.385 | Heat shock protein 90 alpha antagonist | 0.385 0.006 CID_66 | CID_66 | |
| 0.196 | 0.036 | 0.196 | Cyclooxygenase 1 inhibitor | 0.152 0.056 CID_66 | ||
| 0.185 | 0.025 | 0.185 | Nav1.6 sodium channel blocker | 0.123 0.092 CID_66 | ||
| 0.163 | 0.004 | 0.163 | GABA B receptor agonist | 0.162 0.004 CID_66 | ||
| 0.274 | 0.115 | 0.417 | Prostaglandin dehydrogenase inhibitor | 0.417 0.062 CID_66 | CID_66 | |
| 0.167 | 0.01 | 0.167 | Carbamoyl phosphate synthetase inhibitor | 0.128 0.014 CID_66 | ||
| 0.163 | 0.008 | 0.163 | Biliverdin reductase inhibitor | 0.095 0.02 CID_66 | ||
| 0.159 | 0.005 | 0.159 | D-Ala-D-Ala ligase inhibitor | 0.158 0.005 CID_66 | ||
| 0.294 | 0.14 | 0.352 | Antibacterial | 0.352 0.101 CID_66 | CID_66 | |
| 0.168 | 0.015 | 0.168 | Phosphofructokinase-1 inhibitor | 0.144 0.019 CID_66 | ||
| 0.183 | 0.031 | 0.183 | Nav1.3 sodium channel blocker | 0.137 0.057 CID_66 | ||
| 0.157 | 0.004 | 0.157 | NMDA receptor glycine site agonist | 0.122 0.008 CID_66 | ||
| 0.205 | 0.053 | 0.205 | Mcl-1 antagonist | 0.186 0.064 CID_66 | ||
| 0.187 | 0.035 | 0.187 | Cyclooxygenase 2 inhibitor | 0.146 0.057 CID_66 | ||
| 0.162 | 0.011 | 0.162 | Acetylcholine release stimulant | 0.112 0.062 CID_66 | ||
| 0.172 | 0.021 | 0.172 | Falcipain 2 inhibitor | |||
| 0.173 | 0.022 | 0.173 | Falcipain inhibitor | |||
| 0.159 | 0.009 | 0.159 | Glutamate (mGluR7) agonist | 0.111 0.041 CID_66 | ||
| 0.152 | 0.004 | 0.152 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.04 CID_66 | ||
| 0.156 | 0.01 | 0.156 | Prostaglandin antagonist | |||
| 0.19 | 0.043 | 0.19 | Death-associated protein kinase 2 inhibitor | 0.141 0.13 CID_66 | ||
| 0.162 | 0.016 | 0.162 | Potassium channel activator | 0.105 0.043 CID_66 | ||
| 0.164 | 0.019 | 0.164 | CDK3/cyclin E inhibitor | 0.156 0.023 CID_66 | ||
| 0.161 | 0.016 | 0.189 | Transcription factor STAT6 inhibitor | 0.189 0.008 CID_66 | CID_66 | |
| 0.234 | 0.09 | 0.234 | DNA damaging | 0.164 0.152 CID_66 | ||
| 0.159 | 0.014 | 0.159 | Glutamate dehydrogenase inhibitor | 0.127 0.021 CID_66 | ||
| 0.149 | 0.005 | 0.149 | Aryl hydrocarbon receptor antagonist | 0.09 0.019 CID_66 | ||
| 0.205 | 0.062 | 0.205 | Histone acetyltransferase inhibitor | 0.152 0.137 CID_66 | ||
| 0.163 | 0.021 | 0.163 | NMDA receptor antagonist | 0.147 0.025 CID_66 | ||
| 0.166 | 0.024 | 0.166 | EphA2 antagonist | 0.099 0.076 CID_66 | ||
| 0.175 | 0.034 | 0.175 | Neuropeptide Y1 antagonist | 0.16 0.051 CID_66 | ||
| 0.16 | 0.019 | 0.188 | Urease inhibitor | 0.188 0.012 CID_66 | CID_66 | |
| 0.21 | 0.069 | 0.21 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.154 | 0.015 | 0.164 | MAP kinase kinase 1 inhibitor | 0.164 0.012 CID_66 | CID_66 | |
| 0.169 | 0.03 | 0.169 | Aminopeptidase B inhibitor | 0.134 0.045 CID_66 | ||
| 0.142 | 0.004 | 0.142 | Vanilloid 4 agonist | 0.112 0.01 CID_66 | ||
| 0.153 | 0.015 | 0.153 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.145 | 0.01 | 0.145 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 CID_66 | ||
| 0.204 | 0.07 | 0.204 | Insulin sensitizer | 0.181 0.095 CID_66 | ||
| 0.147 | 0.014 | 0.147 | Cyclin B3 inhibitor | 0.115 0.023 CID_66 | ||
| 0.156 | 0.024 | 0.156 | Nav1.5 sodium channel blocker | 0.116 0.06 CID_66 | ||
| 0.231 | 0.1 | 0.231 | Spasmolytic | 0.183 0.134 CID_66 | ||
| 0.149 | 0.018 | 0.149 | Anabolic | 0.141 0.023 CID_66 | ||
| 0.138 | 0.007 | 0.172 | NMDA receptor subunit 3B antagonist | 0.172 0.005 CID_66 | CID_66 | |
| 0.153 | 0.023 | 0.153 | Beta glucuronidase inhibitor | 0.148 0.026 CID_66 | ||
| 0.215 | 0.086 | 0.215 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.134 | 0.004 | 0.134 | Phospholipase D inhibitor | 0.102 0.013 CID_66 | ||
| 0.165 | 0.036 | 0.165 | Antibacterial (Helicobacter pylori) | 0.107 0.104 CID_66 | ||
| 0.199 | 0.07 | 0.213 | DNA methyltransferase I inhibitor | 0.213 0.063 CID_66 | CID_66 | |
| 0.205 | 0.076 | 0.205 | DNA methylase inhibitor | 0.205 0.076 CID_66 | ||
| 0.189 | 0.06 | 0.189 | Tumour necrosis factor antagonist | |||
| 0.161 | 0.032 | 0.161 | Falcipain 3 inhibitor | 0.091 0.08 CID_66 | ||
| 0.137 | 0.009 | 0.153 | Purinergic P2X1 antagonist | 0.153 0.007 CID_66 | CID_66 | |
| 0.18 | 0.051 | 0.18 | Cyclin-dependent kinase 8 inhibitor | 0.15 0.08 CID_66 | ||
| 0.239 | 0.11 | 0.252 | Hypoxia-inducible factor 1 alpha inhibitor | 0.252 0.099 CID_66 | CID_66 | |
| 0.132 | 0.004 | 0.132 | Calcium channel P-type blocker | 0.083 0.013 CID_66 | ||
| 0.135 | 0.007 | 0.135 | Bcl2 antagonist | 0.104 0.016 CID_66 | ||
| 0.154 | 0.026 | 0.157 | AMP-activated protein kinase stimulant | 0.157 0.024 CID_66 | CID_66 | |
| 0.194 | 0.066 | 0.194 | LIM domain kinase 1 inhibitor | 0.147 0.101 CID_66 | ||
| 0.176 | 0.05 | 0.176 | Thiol protease inhibitor | 0.136 0.086 CID_66 | ||
| 0.129 | 0.005 | 0.129 | Glutamate (mGluR6) antagonist | 0.099 0.011 CID_66 | ||
| 0.136 | 0.011 | 0.136 | TRPA1 antagonist | 0.088 0.021 CID_66 | ||
| 0.132 | 0.007 | 0.132 | Dopamine transporter inhibitor | 0.058 0.026 CID_66 | ||
| 0.169 | 0.045 | 0.169 | Sodium channel blocker | 0.123 0.081 CID_66 | ||
| 0.171 | 0.048 | 0.171 | Hemostatic | 0.124 0.107 CID_66 | ||
| 0.134 | 0.012 | 0.134 | T cell inhibitor | 0.09 0.038 CID_66 | ||
| 0.178 | 0.056 | 0.178 | Interleukin 6 antagonist | |||
| 0.137 | 0.015 | 0.137 | Prostaglandin-E synthase inhibitor | 0.108 0.023 CID_66 | ||
| 0.137 | 0.016 | 0.137 | Glutamate decarboxylase inhibitor | 0.13 0.018 CID_66 | ||
| 0.176 | 0.054 | 0.186 | Melanin inhibitor | 0.186 0.048 CID_66 | CID_66 | |
| 0.128 | 0.007 | 0.128 | 5 Hydroxytryptamine 3 agonist | 0.071 0.034 CID_66 | ||
| 0.133 | 0.012 | 0.133 | Benzodiazepine agonist | 0.064 0.06 CID_66 | ||
| 0.174 | 0.053 | 0.352 | Heat shock protein 90 antagonist | 0.352 0.005 CID_66 | CID_66 | |
| 0.124 | 0.004 | 0.124 | MDM2 inhibitor | 0.114 0.004 CID_66 | ||
| 0.135 | 0.016 | 0.135 | Glutathione S-transferase inhibitor | 0.123 0.021 CID_66 | ||
| 0.138 | 0.019 | 0.138 | Inducible nitric-oxide synthase inhibitor | 0.101 0.036 CID_66 | ||
| 0.131 | 0.013 | 0.131 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 CID_66 | ||
| 0.166 | 0.048 | 0.166 | Interleukin 1 antagonist | |||
| 0.162 | 0.044 | 0.162 | Toll-Like receptor 2 antagonist | 0.153 0.05 CID_66 | ||
| 0.245 | 0.127 | 0.267 | Thyroid hormone antagonist | 0.267 0.113 CID_66 | CID_66 | |
| 0.122 | 0.005 | 0.122 | Nicotinic alpha3beta2 receptor antagonist | 0.08 0.013 CID_66 | ||
| 0.121 | 0.004 | 0.121 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 CID_66 | ||
| 0.121 | 0.004 | 0.121 | Corticotropin releasing factor 2 receptor antagonist | 0.083 0.014 CID_66 | ||
| 0.133 | 0.017 | 0.133 | Interleukin 5 antagonist | 0.096 0.046 CID_66 | ||
| 0.121 | 0.004 | 0.121 | Bromodomain-containing protein 3 inhibitor | |||
| 0.122 | 0.005 | 0.122 | Aconitate hydratase inhibitor | 0.079 0.014 CID_66 | ||
| 0.141 | 0.025 | 0.141 | Phosphodiesterase 7B inhibitor | |||
| 0.142 | 0.027 | 0.142 | Hedgehog signaling inhibitor | |||
| 0.151 | 0.035 | 0.151 | GABA receptor agonist | |||
| 0.239 | 0.125 | 0.254 | Thyroid hormone beta antagonist | 0.254 0.116 CID_66 | CID_66 | |
| 0.138 | 0.025 | 0.138 | Alcohol dehydrogenase inhibitor | 0.138 0.024 CID_66 | ||
| 0.248 | 0.135 | 0.248 | Thioredoxin glutathione reductase inhibitor | |||
| 0.136 | 0.024 | 0.136 | Carbonic anhydrase VI inhibitor | 0.109 0.034 CID_66 | ||
| 0.132 | 0.02 | 0.132 | NMDA 2 receptor antagonist | 0.118 0.024 CID_66 | ||
| 0.145 | 0.034 | 0.145 | Photosensitizer | 0.114 0.065 CID_66 | ||
| 0.122 | 0.01 | 0.122 | Cannabinoid CB2 receptor antagonist | 0.08 0.02 CID_66 | ||
| 0.158 | 0.047 | 0.173 | MAP kinase kinase inhibitor | 0.173 0.04 CID_66 | CID_66 | |
| 0.121 | 0.011 | 0.121 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.086 0.018 CID_66 | ||
| 0.123 | 0.014 | 0.123 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 CID_66 | ||
| 0.137 | 0.028 | 0.137 | Prolactin inhibitor | 0.109 0.047 CID_66 | ||
| 0.113 | 0.004 | 0.113 | Potassium channel (Inward rectifier) activator | 0.077 0.009 CID_66 | ||
| 0.114 | 0.004 | 0.114 | Purinergic P2X7 antagonist | |||
| 0.167 | 0.057 | 0.167 | Protein kinase stimulant | 0.128 0.085 CID_66 | ||
| 0.12 | 0.011 | 0.12 | Acetylcholine M5 receptor agonist | |||
| 0.235 | 0.126 | 0.235 | Caspase 3 stimulant | 0.226 0.136 CID_66 | ||
| 0.163 | 0.055 | 0.176 | MAO inhibitor | 0.176 0.049 CID_66 | CID_66 | |
| 0.112 | 0.003 | 0.112 | p53 inhibitor | 0.048 0.015 CID_66 | ||
| 0.152 | 0.044 | 0.176 | Adenylate cyclase inhibitor | 0.176 0.031 CID_66 | CID_66 | |
| 0.11 | 0.003 | 0.11 | Alpha 1L adrenoreceptor agonist | 0.048 0.019 CID_66 | ||
| 0.112 | 0.004 | 0.112 | CC chemokine 4 receptor antagonist | 0.063 0.014 CID_66 | ||
| 0.111 | 0.004 | 0.111 | Carnitine palmitoyltransferase 1B inhibitor | 0.045 0.039 CID_66 | ||
| 0.111 | 0.004 | 0.111 | Potassium channel (ATP-sensitive) activator | 0.074 0.008 CID_66 | ||
| 0.135 | 0.028 | 0.135 | Interleukin 2 antagonist | |||
| 0.142 | 0.036 | 0.147 | CC chemokine 6 receptor antagonist | 0.147 0.027 CID_66 | CID_66 | |
| 0.128 | 0.022 | 0.234 | Macrophage migration inhibitory factor inhibitor | 0.234 0.005 CID_66 | CID_66 | |
| 0.115 | 0.01 | 0.115 | 5 Hydroxytryptamine 2A agonist | 0.096 0.016 CID_66 | ||
| 0.143 | 0.038 | 0.143 | DNA repair enzyme inhibitor | 0.124 0.064 CID_66 | ||
| 0.11 | 0.005 | 0.11 | Factor XIa inhibitor | |||
| 0.145 | 0.04 | 0.145 | Microtubule formation inhibitor | 0.13 0.051 CID_66 | ||
| 0.112 | 0.008 | 0.112 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.036 CID_66 | ||
| 0.107 | 0.004 | 0.107 | Adenylate cyclase 1 inhibitor | 0.083 0.007 CID_66 | ||
| 0.197 | 0.093 | 0.197 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.111 | 0.008 | 0.126 | NMDA receptor subunit 3A antagonist | 0.126 0.006 CID_66 | CID_66 | |
| 0.132 | 0.029 | 0.132 | Calcium antagonist | |||
| 0.133 | 0.031 | 0.133 | Nitric-oxide synthase inhibitor | 0.09 0.078 CID_66 | ||
| 0.146 | 0.044 | 0.146 | Beta amyloid protein antagonist | |||
| 0.106 | 0.004 | 0.106 | Dihydroorotate oxidase inhibitor | 0.089 0.007 CID_66 | ||
| 0.116 | 0.015 | 0.116 | Dopamine uptake inhibitor | 0.079 0.026 CID_66 | ||
| 0.128 | 0.027 | 0.128 | Carbonic anhydrase XIII inhibitor | 0.093 0.041 CID_66 | ||
| 0.119 | 0.02 | 0.119 | Myeloperoxidase inhibitor | 0.11 0.026 CID_66 | ||
| 0.119 | 0.02 | 0.119 | Bile acid receptor antagonist | 0.118 0.021 CID_66 | ||
| 0.101 | 0.004 | 0.114 | Pregnane X receptor antagonist | 0.114 0.003 CID_66 | CID_66 | |
| 0.107 | 0.009 | 0.107 | Glutamate (mGluR group III) agonist | 0.082 0.013 CID_66 | ||
| 0.174 | 0.077 | 0.267 | Dual specificity phosphatase 3 inhibitor | 0.267 0.036 CID_66 | CID_66 | |
| 0.117 | 0.02 | 0.117 | Aminopeptidase I inhibitor | 0.09 0.034 CID_66 | ||
| 0.219 | 0.122 | 0.245 | Lipoxygenase inhibitor | 0.245 0.103 CID_66 | CID_66 | |
| 0.113 | 0.016 | 0.113 | Argininosuccinate synthase inhibitor | 0.077 0.026 CID_66 | ||
| 0.111 | 0.014 | 0.125 | Estrogen-related receptor beta agonist | 0.125 0.008 CID_66 | CID_66 | |
| 0.21 | 0.114 | 0.21 | Immunostimulant | 0.204 0.118 CID_66 | ||
| 0.182 | 0.087 | 0.182 | I kappa B kinase epsilon inhibitor | |||
| 0.117 | 0.022 | 0.133 | Nav1.8 sodium channel blocker | 0.133 0.017 CID_66 | CID_66 | |
| 0.108 | 0.013 | 0.108 | NMDA 2C receptor antagonist | 0.085 0.022 CID_66 | ||
| 0.123 | 0.029 | 0.123 | Potassium channel (Voltage-sensitive) activator | |||
| 0.114 | 0.02 | 0.114 | mTOR complex 2 inhibitor | 0.085 0.058 CID_66 | ||
| 0.112 | 0.019 | 0.112 | Nav1.7 sodium channel blocker | 0.071 0.042 CID_66 | ||
| 0.138 | 0.045 | 0.138 | Alpha 2b adrenoreceptor antagonist | 0.089 0.087 CID_66 | ||
| 0.098 | 0.004 | 0.102 | Dopamine D5 agonist | 0.102 0.004 CID_66 | CID_66 | |
| 0.136 | 0.043 | 0.151 | MAO B inhibitor | 0.151 0.037 CID_66 | CID_66 | |
| 0.105 | 0.012 | 0.105 | NMDA 2A receptor antagonist | 0.085 0.018 CID_66 | ||
| 0.116 | 0.023 | 0.126 | HIV-1 reverse transcriptase inhibitor | 0.126 0.02 CID_66 | CID_66 | |
| 0.102 | 0.009 | 0.102 | Glutamate (mGluR7) antagonist | 0.073 0.037 CID_66 | ||
| 0.138 | 0.046 | 0.138 | Calcium channel N-type blocker | |||
| 0.101 | 0.009 | 0.101 | Potassium channel (Tandem pore domain) blocker | 0.069 0.067 CID_66 | ||
| 0.095 | 0.003 | 0.117 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.117 0.002 CID_66 | CID_66 | |
| 0.1 | 0.008 | 0.1 | Sphingosine kinase 2 inhibitor | 0.075 0.018 CID_66 | ||
| 0.118 | 0.026 | 0.118 | Protein kinase B gamma inhibitor | |||
| 0.267 | 0.175 | 0.267 | Transcription factor inhibitor | |||
| 0.107 | 0.015 | 0.107 | CC chemokine 5 receptor agonist | 0.09 0.036 CID_66 | ||
| 0.158 | 0.067 | 0.158 | Acetylcholine M1 receptor antagonist | |||
| 0.122 | 0.031 | 0.143 | Protein kinase C zeta inhibitor | 0.143 0.022 CID_66 | CID_66 | |
| 0.096 | 0.004 | 0.096 | Glutamate (mGluR3) antagonist | 0.054 0.011 CID_66 | ||
| 0.096 | 0.005 | 0.096 | GABA B receptor antagonist | 0.052 0.017 CID_66 | ||
| 0.095 | 0.005 | 0.095 | Kallikrein 7 inhibitor | 0.068 0.032 CID_66 | ||
| 0.118 | 0.028 | 0.118 | Cathepsin G inhibitor | 0.069 0.055 CID_66 | ||
| 0.1 | 0.01 | 0.173 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.173 0.004 CID_66 | CID_66 | |
| 0.14 | 0.05 | 0.152 | Vanilloid 1 agonist | 0.152 0.036 CID_66 | CID_66 | |
| 0.099 | 0.009 | 0.099 | 5 Hydroxytryptamine 2 agonist | 0.086 0.013 CID_66 | ||
| 0.093 | 0.004 | 0.093 | 5 Hydroxytryptamine 2B agonist | 0.057 0.009 CID_66 | ||
| 0.178 | 0.09 | 0.178 | Focal adhesion kinase 2 inhibitor | |||
| 0.108 | 0.02 | 0.108 | Amidase inhibitor | 0.07 0.049 CID_66 | ||
| 0.101 | 0.013 | 0.101 | Phosphorylase inhibitor | 0.063 0.023 CID_66 | ||
| 0.094 | 0.006 | 0.094 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 CID_66 | ||
| 0.145 | 0.057 | 0.145 | Aurora-C kinase inhibitor | |||
| 0.091 | 0.004 | 0.091 | Kynurenine 3 monooxygenase inhibitor | 0.086 0.004 CID_66 | ||
| 0.266 | 0.181 | 0.266 | DNA directed DNA polymerase inhibitor | |||
| 0.088 | 0.004 | 0.088 | Heme oxygenase inhibitor | 0.054 0.009 CID_66 | ||
| 0.089 | 0.004 | 0.089 | Alpha 1d adrenoreceptor agonist | 0.05 0.017 CID_66 | ||
| 0.089 | 0.005 | 0.089 | Purinergic P2X4 antagonist | 0.083 0.006 CID_66 | ||
| 0.094 | 0.011 | 0.094 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 CID_66 | ||
| 0.129 | 0.045 | 0.129 | Protein kinase C gamma inhibitor | |||
| 0.103 | 0.02 | 0.103 | Sphingosine 1-phosphate receptor antagonist | 0.094 0.026 CID_66 | ||
| 0.099 | 0.016 | 0.099 | Carbonic anhydrase VB inhibitor | 0.059 0.036 CID_66 | ||
| 0.089 | 0.007 | 0.089 | Secretase gamma inhibitor | |||
| 0.12 | 0.038 | 0.12 | Ca(v)2.2 blocker | |||
| 0.105 | 0.023 | 0.105 | Caspase 7 inhibitor | 0.077 0.068 CID_66 | ||
| 0.113 | 0.032 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 CID_66 | CID_66 | |
| 0.129 | 0.048 | 0.129 | Caspase 3 inhibitor | 0.105 0.083 CID_66 | ||
| 0.152 | 0.072 | 0.152 | Phospholipase A2 inhibitor | 0.148 0.076 CID_66 | ||
| 0.105 | 0.025 | 0.119 | Carbonic anhydrase V inhibitor | 0.119 0.022 CID_66 | CID_66 | |
| 0.083 | 0.004 | 0.083 | Nerve growth factor antagonist | 0.059 0.01 CID_66 | ||
| 0.084 | 0.005 | 0.084 | Potassium channel Kv1.1 blocker | 0.039 0.024 CID_66 | ||
| 0.181 | 0.102 | 0.181 | HERG channel blocker | |||
| 0.088 | 0.01 | 0.088 | 5 Hydroxytryptamine 7 agonist | 0.054 0.042 CID_66 | ||
| 0.086 | 0.008 | 0.086 | CC chemokine receptor 2B antagonist | |||
| 0.124 | 0.046 | 0.139 | Protein kinase (CK2) inhibitor | 0.139 0.038 CID_66 | CID_66 | |
| 0.098 | 0.02 | 0.098 | Cannabinoid CB1 receptor agonist | |||
| 0.141 | 0.064 | 0.201 | Farnesoid X receptor antagonist | 0.201 0.021 CID_66 | CID_66 | |
| 0.094 | 0.017 | 0.107 | Androgen agonist | 0.107 0.012 CID_66 | CID_66 | |
| 0.086 | 0.01 | 0.086 | Aldosterone antagonist | 0.05 0.029 CID_66 | ||
| 0.101 | 0.025 | 0.101 | Carbonic anhydrase VA inhibitor | 0.072 0.044 CID_66 | ||
| 0.108 | 0.032 | 0.108 | Glutamate receptor agonist | |||
| 0.085 | 0.009 | 0.085 | Glutamate (mGluR5) agonist | |||
| 0.09 | 0.014 | 0.138 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.138 0.005 CID_66 | CID_66 | |
| 0.133 | 0.058 | 0.133 | Anesthetic local | |||
| 0.113 | 0.038 | 0.141 | Androgen antagonist | 0.141 0.025 CID_66 | CID_66 | |
| 0.125 | 0.05 | 0.125 | Mucolytic | 0.105 0.071 CID_66 | ||
| 0.089 | 0.015 | 0.196 | Heat shock protein 90 beta antagonist | 0.196 0.004 CID_66 | CID_66 | |
| 0.079 | 0.005 | 0.079 | Benzodiazepine antagonist | 0.053 0.021 CID_66 | ||
| 0.151 | 0.077 | 0.151 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.081 | 0.007 | 0.081 | Fumarate hydratase inhibitor | 0.054 0.012 CID_66 | ||
| 0.131 | 0.058 | 0.131 | Cell adhesion inhibitor | |||
| 0.081 | 0.008 | 0.081 | Glutamate (mGluR4) antagonist | 0.045 0.027 CID_66 | ||
| 0.091 | 0.018 | 0.091 | Alpha 2 adrenoreceptor agonist | |||
| 0.257 | 0.184 | 0.257 | Alpha-glucosidase inhibitor | 0.245 0.191 CID_66 | ||
| 0.091 | 0.018 | 0.091 | GABA receptor antagonist | 0.052 0.042 CID_66 | ||
| 0.104 | 0.032 | 0.104 | Cell adhesion molecule inhibitor | |||
| 0.114 | 0.041 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.062 CID_66 | ||
| 0.08 | 0.008 | 0.08 | Fructose-1,6-bisphosphatase inhibitor | 0.056 0.019 CID_66 | ||
| 0.077 | 0.005 | 0.082 | Dopamine beta hydroxylase inhibitor | 0.082 0.005 CID_66 | CID_66 | |
| 0.183 | 0.112 | 0.183 | Antiamyloidogenic | 0.183 0.112 CID_66 | ||
| 0.075 | 0.004 | 0.2 | ATP citrate lysase inhibitor | 0.2 0.002 CID_66 | CID_66 | |
| 0.117 | 0.046 | 0.117 | Toll-Like receptor 4 antagonist | |||
| 0.09 | 0.019 | 0.09 | GABA A receptor antagonist | 0.049 0.043 CID_66 | ||
| 0.083 | 0.012 | 0.083 | Glutamate (mGluR group I) agonist | 0.044 0.038 CID_66 | ||
| 0.092 | 0.021 | 0.092 | MAP kinase kinase 7 inhibitor | 0.089 0.026 CID_66 | ||
| 0.075 | 0.005 | 0.075 | Factor XI inhibitor | |||
| 0.136 | 0.066 | 0.167 | Death-associated protein kinase 1 inhibitor | 0.167 0.021 CID_66 | CID_66 | |
| 0.093 | 0.023 | 0.093 | Secretase beta inhibitor | |||
| 0.086 | 0.016 | 0.086 | Phosphodiesterase 1C inhibitor | |||
| 0.096 | 0.027 | 0.096 | CXC chemokine receptor antagonist | |||
| 0.08 | 0.011 | 0.08 | 5 Hydroxytryptamine 2C agonist | 0.052 0.026 CID_66 | ||
| 0.074 | 0.004 | 0.074 | Protein kinase (CK2) beta inhibitor | 0.056 0.005 CID_66 | ||
| 0.139 | 0.07 | 0.139 | Toll-Like receptor 9 antagonist | |||
| 0.1 | 0.032 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.092 0.039 CID_66 | ||
| 0.076 | 0.007 | 0.076 | Kainate receptor 2 antagonist | 0.043 0.02 CID_66 | ||
| 0.126 | 0.058 | 0.133 | Protein kinase (CK2) alpha inhibitor | 0.133 0.053 CID_66 | CID_66 | |
| 0.096 | 0.028 | 0.096 | Transforming growth factor beta 3 antagonist | |||
| 0.119 | 0.051 | 0.119 | MAP kinase kinase kinase inhibitor | |||
| 0.08 | 0.013 | 0.08 | Epithelial sodium channel blocker | 0.062 0.026 CID_66 | ||
| 0.071 | 0.004 | 0.071 | Kainate receptor agonist | 0.057 0.008 CID_66 | ||
| 0.084 | 0.018 | 0.084 | Thromboxane antagonist | 0.063 0.03 CID_66 | ||
| 0.077 | 0.011 | 0.077 | Squalene epoxidase inhibitor | 0.054 0.027 CID_66 | ||
| 0.119 | 0.053 | 0.126 | MAO A inhibitor | 0.126 0.049 CID_66 | CID_66 | |
| 0.071 | 0.006 | 0.071 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.06 0.007 CID_66 | ||
| 0.074 | 0.009 | 0.093 | Phosphoglycerate kinase inhibitor | 0.093 0.007 CID_66 | CID_66 | |
| 0.074 | 0.009 | 0.074 | Cholesterol esterase inhibitor | 0.047 0.035 CID_66 | ||
| 0.081 | 0.016 | 0.081 | Glycine transporter inhibitor | |||
| 0.079 | 0.014 | 0.079 | Sphingosine 1-phosphate receptor 1 antagonist | 0.071 0.018 CID_66 | ||
| 0.087 | 0.022 | 0.087 | Potassium channel (ATP-sensitive) blocker | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 CID_66 | ||
| 0.086 | 0.023 | 0.086 | Potassium channel Kv1.5 blocker | |||
| 0.081 | 0.017 | 0.081 | Cyclin D1 inhibitor | 0.057 0.048 CID_66 | ||
| 0.068 | 0.005 | 0.068 | Histamine H1 receptor agonist | |||
| 0.093 | 0.03 | 0.093 | Adenosine A3 receptor antagonist | 0.072 0.055 CID_66 | ||
| 0.135 | 0.072 | 0.135 | Calcium channel blocker | |||
| 0.068 | 0.005 | 0.068 | CXC chemokine 3 receptor antagonist | |||
| 0.078 | 0.016 | 0.078 | Glucosylceramidase inhibitor | 0.057 0.036 CID_66 | ||
| 0.174 | 0.112 | 0.174 | Potassium channel blocker | |||
| 0.073 | 0.011 | 0.073 | Kainate receptor antagonist | 0.045 0.025 CID_66 | ||
| 0.079 | 0.019 | 0.079 | Autotaxin inhibitor | 0.049 0.042 CID_66 | ||
| 0.065 | 0.005 | 0.065 | Glutamate (mGluR8) agonist | 0.058 0.008 CID_66 | ||
| 0.076 | 0.017 | 0.076 | Thromboxane A2 antagonist | 0.06 0.028 CID_66 | ||
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.063 | 0.005 | 0.063 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.031 CID_66 | ||
| 0.078 | 0.019 | 0.078 | Transcription factor RelA inhibitor | 0.064 0.043 CID_66 | ||
| 0.066 | 0.008 | 0.066 | Sirtuin 2 inhibitor | 0.03 0.025 CID_66 | ||
| 0.064 | 0.006 | 0.064 | Integrin alpha2 antagonist | 0.04 0.021 CID_66 | ||
| 0.063 | 0.005 | 0.063 | LFA antagonist | 0.025 0.024 CID_66 | ||
| 0.27 | 0.212 | 0.27 | MAP kinase 1 inhibitor | 0.265 0.217 CID_66 | ||
| 0.081 | 0.023 | 0.081 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.062 | 0.005 | 0.062 | NMDA receptor glycine site antagonist | 0.046 0.007 CID_66 | ||
| 0.061 | 0.004 | 0.061 | Alpha 2a adrenoreceptor agonist | 0.03 0.005 CID_66 | ||
| 0.083 | 0.026 | 0.116 | Aromatase inhibitor | 0.116 0.018 CID_66 | CID_66 | |
| 0.062 | 0.005 | 0.062 | Vanilloid 3 antagonist | 0.044 0.014 CID_66 | ||
| 0.061 | 0.004 | 0.082 | CF transmembrane conductance regulator antagonist | 0.082 0.003 CID_66 | CID_66 | |
| 0.065 | 0.008 | 0.065 | GABA uptake inhibitor | 0.043 0.022 CID_66 | ||
| 0.092 | 0.035 | 0.092 | Acetylcholine M4 receptor antagonist | |||
| 0.072 | 0.015 | 0.072 | Alpha-mannosidase inhibitor | 0.059 0.029 CID_66 | ||
| 0.086 | 0.03 | 0.19 | Dopamine D1 antagonist | 0.19 0.011 CID_66 | CID_66 | |
| 0.084 | 0.028 | 0.084 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.076 | 0.021 | 0.076 | CC chemokine 2 receptor antagonist | 0.061 0.032 CID_66 | ||
| 0.067 | 0.011 | 0.067 | Glycine transporter 1 inhibitor | |||
| 0.08 | 0.025 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 CID_66 | CID_66 | |
| 0.248 | 0.193 | 0.248 | DNA polymerase beta inhibitor | |||
| 0.075 | 0.02 | 0.075 | Sphingosine kinase inhibitor | 0.058 0.042 CID_66 | ||
| 0.077 | 0.023 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 CID_66 | ||
| 0.063 | 0.008 | 0.063 | Glutamate (mGluR4) agonist | 0.037 0.019 CID_66 | ||
| 0.067 | 0.013 | 0.067 | Dihydroorotase inhibitor | 0.041 0.037 CID_66 | ||
| 0.063 | 0.009 | 0.063 | Farnesoid X receptor agonist | 0.059 0.01 CID_66 | ||
| 0.067 | 0.014 | 0.067 | Histamine H4 receptor antagonist | |||
| 0.075 | 0.021 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 CID_66 | ||
| 0.099 | 0.045 | 0.099 | Phosphodiesterase I inhibitor | |||
| 0.065 | 0.011 | 0.065 | Glutamate (mGluR group III) antagonist | 0.041 0.038 CID_66 | ||
| 0.079 | 0.026 | 0.079 | Phosphodiesterase VII inhibitor | |||
| 0.063 | 0.009 | 0.063 | Guanylate cyclase inhibitor | 0.051 0.02 CID_66 | ||
| 0.078 | 0.025 | 0.078 | Beta 3 adrenoreceptor antagonist | 0.07 0.034 CID_66 | ||
| 0.058 | 0.005 | 0.058 | Prostaglandin EP1 antagonist | |||
| 0.115 | 0.062 | 0.115 | Calcium channel (voltage-sensitive) blocker | |||
| 0.127 | 0.075 | 0.127 | Toll-Like receptor antagonist | |||
| 0.139 | 0.086 | 0.139 | Insulin secretagoues | |||
| 0.131 | 0.079 | 0.131 | Cytokine production inhibitor | |||
| 0.064 | 0.013 | 0.064 | Histamine H2 receptor agonist | |||
| 0.061 | 0.009 | 0.061 | Diamine oxidase inhibitor | |||
| 0.073 | 0.021 | 0.073 | Phosphodiesterase 1A inhibitor | |||
| 0.063 | 0.011 | 0.063 | Geranyltranstransferase inhibitor | 0.044 0.031 CID_66 | ||
| 0.056 | 0.004 | 0.056 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 CID_66 | ||
| 0.122 | 0.071 | 0.122 | Epidermal growth factor receptor kinase inhibitor | 0.11 0.084 CID_66 | ||
| 0.083 | 0.032 | 0.083 | Dopamine D4 antagonist | 0.075 0.034 CID_66 | ||
| 0.056 | 0.005 | 0.056 | Ceramide glucosyltransferase inhibitor | 0.052 0.005 CID_66 | ||
| 0.215 | 0.165 | 0.226 | Interleukin 2 agonist | 0.226 0.148 CID_66 | CID_66 | |
| 0.058 | 0.008 | 0.058 | Delayed rectifier potassium channel blocker | |||
| 0.073 | 0.023 | 0.073 | Fatty acid synthase inhibitor | 0.064 0.031 CID_66 | ||
| 0.068 | 0.017 | 0.092 | Adenine nucleotide translocase inhibitor | 0.092 0.005 CID_66 | CID_66 | |
| 0.056 | 0.005 | 0.063 | Sodium/glucose cotransporter 2 inhibitor | 0.063 0.005 CID_66 | CID_66 | |
| 0.063 | 0.013 | 0.063 | Thymidine kinase inhibitor | 0.056 0.015 CID_66 | ||
| 0.076 | 0.026 | 0.092 | Prostaglandin F2 alpha antagonist | 0.092 0.015 CID_66 | CID_66 | |
| 0.086 | 0.036 | 0.086 | Epoxide hydrolase inhibitor | |||
| 0.067 | 0.018 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 CID_66 | ||
| 0.083 | 0.034 | 0.083 | I kappa B kinase 1 inhibitor | 0.07 0.048 CID_66 | ||
| 0.056 | 0.006 | 0.056 | Uridine phosphorylase inhibitor | 0.047 0.009 CID_66 | ||
| 0.06 | 0.01 | 0.06 | Dihydrofolate reductase inhibitor | 0.052 0.017 CID_66 | ||
| 0.084 | 0.035 | 0.084 | Alpha adrenoreceptor agonist | |||
| 0.099 | 0.05 | 0.099 | Thioredoxin inhibitor | 0.096 0.053 CID_66 | ||
| 0.087 | 0.038 | 0.159 | Estrogen receptor alpha antagonist | 0.159 0.01 CID_66 | CID_66 | |
| 0.075 | 0.026 | 0.075 | Glutamate (mGluR1) antagonist | |||
| 0.054 | 0.005 | 0.054 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.064 | 0.016 | 0.064 | Phosphodiesterase 7A inhibitor | |||
| 0.106 | 0.058 | 0.106 | Ephrin antagonist | 0.091 0.071 CID_66 | ||
| 0.075 | 0.026 | 0.075 | Phosphodiesterase 1B inhibitor | |||
| 0.067 | 0.019 | 0.067 | Potassium channel (Inward rectifier) blocker | |||
| 0.059 | 0.011 | 0.059 | AMPA 4 receptor antagonist | 0.041 0.025 CID_66 | ||
| 0.058 | 0.01 | 0.058 | Vascular adhesion protein 1 inhibitor | |||
| 0.067 | 0.019 | 0.067 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.057 | 0.009 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.052 | 0.005 | 0.052 | Glutamate (mGluR1a) agonist | 0.021 0.017 CID_66 | ||
| 0.06 | 0.013 | 0.06 | Liver X receptor alpha agonist | 0.049 0.02 CID_66 | ||
| 0.081 | 0.035 | 0.081 | Cannabinoid receptor agonist | |||
| 0.091 | 0.045 | 0.091 | Acetylcholine nicotinic agonist | |||
| 0.087 | 0.041 | 0.087 | Interferon agonist | |||
| 0.05 | 0.004 | 0.05 | Integrin alpha2beta1 antagonist | 0.03 0.013 CID_66 | ||
| 0.054 | 0.008 | 0.054 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.072 | 0.026 | 0.072 | Calcium channel T-type blocker | |||
| 0.064 | 0.018 | 0.064 | Heparanase inhibitor | 0.054 0.035 CID_66 | ||
| 0.051 | 0.005 | 0.063 | CXC chemokine 2 receptor antagonist | 0.063 0.005 CID_66 | CID_66 | |
| 0.08 | 0.035 | 0.08 | Orexin receptor 1 antagonist | |||
| 0.099 | 0.054 | 0.099 | Phosphodiesterase 6D inhibitor | |||
| 0.103 | 0.058 | 0.12 | Xanthine oxidase inhibitor | 0.12 0.047 CID_66 | CID_66 | |
| 0.049 | 0.004 | 0.049 | Purinergic P2Y15 antagonist | 0.04 0.007 CID_66 | ||
| 0.064 | 0.02 | 0.064 | Glutamate (mGluR5) antagonist | |||
| 0.065 | 0.021 | 0.065 | Thromboxane synthase inhibitor | 0.05 0.049 CID_66 | ||
| 0.05 | 0.005 | 0.05 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.019 CID_66 | ||
| 0.064 | 0.02 | 0.064 | Topoisomerase II beta inhibitor | 0.049 0.034 CID_66 | ||
| 0.052 | 0.008 | 0.062 | Liver X receptor beta antagonist | 0.062 0.005 CID_66 | CID_66 | |
| 0.105 | 0.061 | 0.105 | Alpha 2c adrenoreceptor antagonist | |||
| 0.087 | 0.043 | 0.087 | MAP kinase 11 inhibitor | |||
| 0.067 | 0.023 | 0.067 | Dihydroorotate dehydrogenase inhibitor | 0.049 0.039 CID_66 | ||
| 0.057 | 0.013 | 0.057 | Dihydropteroate synthase inhibitor | 0.051 0.016 CID_66 | ||
| 0.07 | 0.027 | 0.07 | Acetylcholine muscarinic agonist | |||
| 0.048 | 0.005 | 0.048 | Thymidine phosphorylase inhibitor | 0.031 0.011 CID_66 | ||
| 0.051 | 0.008 | 0.051 | Carnitine palmitoyltransferase inhibitor | |||
| 0.114 | 0.071 | 0.114 | Proteasome inhibitor | |||
| 0.06 | 0.017 | 0.06 | Mannosidase inhibitor | 0.045 0.031 CID_66 | ||
| 0.05 | 0.008 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.063 | 0.02 | 0.063 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.074 | 0.032 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.071 | 0.03 | 0.071 | Acetylcholine M5 receptor antagonist | |||
| 0.046 | 0.005 | 0.046 | MAP3K8 inhibitor | 0.029 0.019 CID_66 | ||
| 0.064 | 0.023 | 0.064 | AMPA receptor antagonist | |||
| 0.06 | 0.019 | 0.06 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.093 | 0.052 | 0.093 | Acetylcholine agonist | |||
| 0.061 | 0.02 | 0.061 | Farnesyltransferase inhibitor | |||
| 0.084 | 0.043 | 0.084 | Keratolytic | 0.079 0.05 CID_66 | ||
| 0.059 | 0.018 | 0.059 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.093 | 0.052 | 0.093 | Ornithine decarboxylase inhibitor | |||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | 0.058 0.033 CID_66 | ||
| 0.072 | 0.032 | 0.072 | Interferon inducer | |||
| 0.065 | 0.025 | 0.065 | MAP kinase kinase 9 inhibitor | |||
| 0.109 | 0.068 | 0.109 | MAP kinase 13 inhibitor | |||
| 0.076 | 0.036 | 0.076 | Protein kinase C beta inhibitor | |||
| 0.087 | 0.047 | 0.087 | Thioredoxin reductase inhibitor | |||
| 0.094 | 0.054 | 0.094 | Polo-like kinase-1 inhibitor | |||
| 0.088 | 0.048 | 0.116 | Adrenaline agonist | 0.116 0.027 CID_66 | CID_66 | |
| 0.06 | 0.021 | 0.06 | Potassium channel Kv1.3 blocker | 0.041 0.04 CID_66 | ||
| 0.077 | 0.038 | 0.086 | Peroxisome proliferator-activated receptor gamma antagonist | 0.086 0.027 CID_66 | CID_66 | |
| 0.049 | 0.01 | 0.049 | Free fatty acid receptor 1 antagonist | 0.042 0.014 CID_66 | ||
| 0.048 | 0.009 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.016 CID_66 | ||
| 0.043 | 0.004 | 0.043 | Imidazoline I1 receptor antagonist | |||
| 0.088 | 0.05 | 0.088 | Histamine H1 receptor antagonist | |||
| 0.051 | 0.013 | 0.051 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | 0.034 0.008 CID_66 | ||
| 0.11 | 0.072 | 0.11 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.086 | 0.048 | 0.086 | Acetylcholine nicotinic antagonist | |||
| 0.077 | 0.039 | 0.077 | Neuronal nicotinic receptor antagonist | |||
| 0.085 | 0.047 | 0.085 | Ca(v)3.1 blocker | |||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | |||
| 0.049 | 0.012 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.043 | 0.006 | 0.045 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 CID_66 | CID_66 | |
| 0.056 | 0.019 | 0.056 | Oxytocin agonist | 0.052 0.023 CID_66 | ||
| 0.057 | 0.02 | 0.057 | Carbonic anhydrase IV inhibitor | |||
| 0.048 | 0.011 | 0.088 | Glucagon receptor antagonist | 0.088 0.005 CID_66 | CID_66 | |
| 0.048 | 0.011 | 0.056 | Liver X receptor beta agonist | 0.056 0.009 CID_66 | CID_66 | |
| 0.048 | 0.012 | 0.09 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.09 0.005 CID_66 | CID_66 | |
| 0.043 | 0.006 | 0.043 | 5 Hydroxytryptamine 6 agonist | |||
| 0.041 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 CID_66 | ||
| 0.069 | 0.033 | 0.069 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.062 | 0.026 | 0.062 | Lysine-specific demethylase 1A inhibitor | |||
| 0.044 | 0.008 | 0.044 | Adenosine uptake inhibitor | |||
| 0.039 | 0.004 | 0.039 | Cyclin T1 inhibitor | 0.018 0.013 CID_66 | ||
| 0.04 | 0.005 | 0.04 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.06 | 0.024 | 0.06 | Bombesin 2 receptor antagonist | |||
| 0.057 | 0.022 | 0.057 | Oleamide hydrolase inhibitor | |||
| 0.043 | 0.008 | 0.043 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.058 | 0.023 | 0.058 | CD45 antagonist | 0.051 0.033 CID_66 | ||
| 0.042 | 0.007 | 0.042 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.047 | 0.012 | 0.047 | Purinergic P2X3 antagonist | 0.032 0.028 CID_66 | ||
| 0.052 | 0.017 | 0.052 | Progesterone antagonist | 0.037 0.024 CID_66 | ||
| 0.043 | 0.008 | 0.094 | CC chemokine 1 receptor antagonist | 0.094 0.004 CID_66 | CID_66 | |
| 0.05 | 0.016 | 0.05 | Glutamate (mGluR group II) antagonist | 0.034 0.033 CID_66 | ||
| 0.049 | 0.015 | 0.049 | Arginase inhibitor | 0.032 0.029 CID_66 | ||
| 0.041 | 0.007 | 0.041 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.054 | 0.02 | 0.054 | Cytokine production stimulant | |||
| 0.056 | 0.022 | 0.056 | Carbonic anhydrase VII inhibitor | 0.054 0.023 CID_66 | ||
| 0.038 | 0.005 | 0.038 | Complement factor 1r inhibitor | |||
| 0.058 | 0.024 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.021 CID_66 | CID_66 | |
| 0.055 | 0.022 | 0.055 | Thymidylate synthase inhibitor | 0.054 0.022 CID_66 | ||
| 0.038 | 0.005 | 0.038 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 CID_66 | ||
| 0.14 | 0.107 | 0.226 | Dual specificity phosphatase inhibitor | 0.226 0.044 CID_66 | CID_66 | |
| 0.065 | 0.032 | 0.074 | Beta 2 adrenoreceptor agonist | 0.074 0.014 CID_66 | CID_66 | |
| 0.049 | 0.016 | 0.049 | TRPM8 blocker | |||
| 0.045 | 0.012 | 0.045 | Integrin alpha1beta1 antagonist | |||
| 0.056 | 0.023 | 0.056 | Acetylcholine M1 receptor agonist | |||
| 0.041 | 0.009 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 CID_66 | CID_66 | |
| 0.045 | 0.013 | 0.045 | VCAM-1 antagonist | |||
| 0.045 | 0.013 | 0.045 | VCAM antagonist | |||
| 0.036 | 0.004 | 0.036 | Complement factor 1s inhibitor | |||
| 0.047 | 0.016 | 0.078 | Nicotinic acid receptor agonist | 0.078 0.007 CID_66 | CID_66 | |
| 0.051 | 0.02 | 0.051 | Parathyroid hormone antagonist | |||
| 0.04 | 0.009 | 0.04 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.038 | 0.007 | 0.038 | Prostaglandin H2 antagonist | 0.027 0.015 CID_66 | ||
| 0.085 | 0.054 | 0.085 | I kappa B kinase inhibitor | 0.082 0.058 CID_66 | ||
| 0.063 | 0.033 | 0.063 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.063 | 0.032 | 0.063 | Bcl-xL inhibitor | 0.058 0.047 CID_66 | ||
| 0.079 | 0.049 | 0.079 | Alpha 2a adrenoreceptor antagonist | |||
| 0.063 | 0.033 | 0.063 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.055 | 0.025 | 0.055 | Adenosine deaminase inhibitor | |||
| 0.043 | 0.012 | 0.043 | AMPA 3 receptor antagonist | |||
| 0.033 | 0.003 | 0.033 | Thromboxane A2 agonist | 0.023 0.004 CID_66 | ||
| 0.057 | 0.027 | 0.057 | Prolyl endopeptidase inhibitor | |||
| 0.051 | 0.021 | 0.051 | AICAR transformylase inhibitor | |||
| 0.049 | 0.019 | 0.086 | Urate transporter 1 inhibitor | 0.086 0.007 CID_66 | CID_66 | |
| 0.036 | 0.006 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.01 CID_66 | ||
| 0.036 | 0.006 | 0.038 | Prostaglandin F2 alpha agonist | 0.038 0.006 CID_66 | CID_66 | |
| 0.111 | 0.081 | 0.111 | MAP kinase 12 inhibitor | |||
| 0.086 | 0.056 | 0.086 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.06 | 0.031 | 0.06 | NMDA 2B receptor antagonist | 0.05 0.043 CID_66 | ||
| 0.04 | 0.011 | 0.04 | Epoxide hydrolase 1 inhibitor | |||
| 0.052 | 0.023 | 0.052 | CC chemokine 3 receptor antagonist | |||
| 0.07 | 0.041 | 0.07 | Orexin receptor antagonist | |||
| 0.084 | 0.055 | 0.084 | ErbB-3 antagonist | |||
| 0.042 | 0.014 | 0.042 | AMPA 1 receptor antagonist | |||
| 0.033 | 0.004 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 CID_66 | ||
| 0.058 | 0.029 | 0.058 | Histamine agonist | |||
| 0.099 | 0.071 | 0.099 | Mediator release inhibitor | |||
| 0.042 | 0.014 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CID_66 | CID_66 | |
| 0.033 | 0.005 | 0.033 | ICAM 1 antagonist | 0.023 0.015 CID_66 | ||
| 0.066 | 0.038 | 0.066 | I kappa B kinase 2 inhibitor | 0.059 0.049 CID_66 | ||
| 0.063 | 0.035 | 0.063 | EphB4 antagonist | 0.061 0.037 CID_66 | ||
| 0.047 | 0.019 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.04 | 0.013 | 0.04 | Cholesterol ester transfer protein antagonist | 0.031 0.023 CID_66 | ||
| 0.031 | 0.004 | 0.031 | CC chemokine 9 receptor antagonist | 0.021 0.006 CID_66 | ||
| 0.063 | 0.036 | 0.063 | Carbonic anhydrase IX inhibitor | |||
| 0.058 | 0.031 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.07 | 0.044 | 0.07 | Leukotriene synthesis inhibitor | |||
| 0.035 | 0.008 | 0.035 | Estrogen-related receptor gamma antagonist | 0.034 0.01 CID_66 | ||
| 0.035 | 0.009 | 0.035 | Kainate receptor 1 antagonist | |||
| 0.121 | 0.095 | 0.121 | Activin receptor-like kinase 2 inhibitor | |||
| 0.029 | 0.003 | 0.029 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_66 | ||
| 0.033 | 0.007 | 0.033 | Vanilloid 2 agonist | 0.029 0.01 CID_66 | ||
| 0.053 | 0.028 | 0.053 | Sodium/calcium exchanger inhibitor | |||
| 0.045 | 0.02 | 0.045 | Membrane dipeptidase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Complement factor D inhibitor | |||
| 0.03 | 0.004 | 0.03 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 CID_66 | ||
| 0.106 | 0.081 | 0.106 | Alkylator | |||
| 0.044 | 0.019 | 0.044 | Delayed rectifier potassium channel activator | |||
| 0.044 | 0.019 | 0.044 | Potassium channel KCNQ activator | |||
| 0.061 | 0.036 | 0.061 | Alpha 1 adrenoreceptor agonist | |||
| 0.058 | 0.033 | 0.058 | Toll-Like receptor 8 antagonist | |||
| 0.039 | 0.015 | 0.039 | Acetylcholine M4 receptor agonist | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase I inhibitor | |||
| 0.033 | 0.009 | 0.033 | Kainate receptor 5 antagonist | |||
| 0.03 | 0.005 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 CID_66 | ||
| 0.037 | 0.013 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.032 | 0.008 | 0.032 | Acid ceramidase inhibitor | |||
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.047 | 0.023 | 0.047 | Glutamate (mGluR1a) antagonist | |||
| 0.096 | 0.073 | 0.096 | Expectorant | |||
| 0.054 | 0.031 | 0.054 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.028 | 0.005 | 0.028 | Alpha 2c adrenoreceptor agonist | |||
| 0.053 | 0.03 | 0.053 | Carbonic anhydrase XIV inhibitor | |||
| 0.062 | 0.039 | 0.062 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.087 | 0.064 | 0.099 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 CID_66 | CID_66 | |
| 0.205 | 0.182 | 0.205 | Ca(v)3.3 blocker | |||
| 0.027 | 0.005 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 CID_66 | CID_66 | |
| 0.07 | 0.048 | 0.07 | Glutamate (mGluR group I) antagonist | |||
| 0.033 | 0.01 | 0.033 | Myristoyl transferase inhibitor | |||
| 0.065 | 0.043 | 0.065 | Carbonic anhydrase inhibitor | |||
| 0.057 | 0.035 | 0.057 | Cannabinoid CB2 receptor agonist | |||
| 0.046 | 0.024 | 0.049 | CDK5/p25 inhibitor | 0.049 0.022 CID_66 | CID_66 | |
| 0.106 | 0.084 | 0.106 | Acetylcholine muscarinic antagonist | 0.102 0.089 CID_66 | ||
| 0.044 | 0.022 | 0.044 | Acid-sensing ion channel blocker | |||
| 0.038 | 0.016 | 0.038 | Dipeptidyl peptidase II inhibitor | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | 0.038 0.03 CID_66 | ||
| 0.058 | 0.037 | 0.058 | Carbonic anhydrase II inhibitor | |||
| 0.045 | 0.025 | 0.045 | Angiotensin AT1 receptor antagonist | |||
| 0.035 | 0.015 | 0.035 | Glutamate (mGluR2) antagonist | |||
| 0.029 | 0.009 | 0.029 | Geranylgeranyltransferase inhibitor | |||
| 0.036 | 0.016 | 0.036 | Prostaglandin agonist | 0.035 0.017 CID_66 | ||
| 0.04 | 0.021 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.029 CID_66 | ||
| 0.038 | 0.019 | 0.044 | RNA-directed RNA polymerase inhibitor | 0.044 0.015 CID_66 | CID_66 | |
| 0.031 | 0.012 | 0.051 | Thyroid hormone agonist | 0.051 0.004 CID_66 | CID_66 | |
| 0.024 | 0.005 | 0.024 | Nicotinic alpha4 receptor agonist | |||
| 0.029 | 0.011 | 0.029 | Glutamate (mGluR1) agonist | 0.024 0.019 CID_66 | ||
| 0.111 | 0.092 | 0.115 | Glycogen synthase kinase-3 alpha inhibitor | 0.115 0.088 CID_66 | CID_66 | |
| 0.085 | 0.067 | 0.085 | Pim-3 kinase inhibitor | |||
| 0.03 | 0.012 | 0.031 | Prostaglandin EP2 agonist | 0.031 0.012 CID_66 | CID_66 | |
| 0.057 | 0.038 | 0.057 | Nicotinic neuronal receptor agonist | |||
| 0.042 | 0.023 | 0.042 | G protein-coupled receptor agonist | |||
| 0.047 | 0.029 | 0.047 | Purinergic P2Y antagonist | |||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase X inhibitor | |||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase VIII inhibitor | |||
| 0.022 | 0.004 | 0.022 | Carbonic anhydrase XI inhibitor | |||
| 0.066 | 0.048 | 0.066 | CDC7 inhibitor | |||
| 0.045 | 0.028 | 0.045 | Dipeptidyl peptidase IV inhibitor | |||
| 0.031 | 0.014 | 0.031 | Urotensin II agonist | |||
| 0.08 | 0.063 | 0.08 | GABA A receptor agonist | |||
| 0.041 | 0.024 | 0.041 | Melanocortin 1 antagonist | |||
| 0.038 | 0.021 | 0.038 | Retinoid X alpha receptor agonist | |||
| 0.056 | 0.039 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 CID_66 | CID_66 | |
| 0.232 | 0.215 | 0.232 | MAP kinase kinase 6 inhibitor | |||
| 0.043 | 0.026 | 0.043 | Antidiuretic hormone antagonist | |||
| 0.041 | 0.024 | 0.041 | MAP3K5 inhibitor | |||
| 0.092 | 0.076 | 0.092 | Gastric antisecretory | |||
| 0.023 | 0.007 | 0.023 | Sodium/hydrogen exchanger inhibitor | |||
| 0.03 | 0.014 | 0.03 | Calcium-sensing receptor agonist | |||
| 0.054 | 0.038 | 0.054 | Nicotinic alpha7 receptor agonist | |||
| 0.02 | 0.004 | 0.02 | Progesterone receptor A antagonist | 0.011 0.005 CID_66 | ||
| 0.023 | 0.007 | 0.023 | G-protein-coupled receptor 120 agonist | 0.019 0.01 CID_66 | ||
| 0.058 | 0.042 | 0.058 | Carbonic anhydrase stimulant | |||
| 0.02 | 0.005 | 0.02 | Integrin beta2 antagonist | |||
| 0.053 | 0.037 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.081 | 0.065 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.022 | 0.007 | 0.022 | CXC chemokine 5 receptor antagonist | |||
| 0.041 | 0.027 | 0.046 | Nicotinic acid receptor 1 agonist | 0.046 0.023 CID_66 | CID_66 | |
| 0.019 | 0.004 | 0.019 | Thromboxane agonist | 0.016 0.004 CID_66 | ||
| 0.035 | 0.02 | 0.035 | Calcium release-activated channel blocker | |||
| 0.03 | 0.016 | 0.03 | Lysine carboxypeptidase inhibitor | |||
| 0.022 | 0.007 | 0.022 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.021 | 0.007 | 0.021 | Telomerase stimulant | 0.019 0.009 CID_66 | ||
| 0.059 | 0.045 | 0.059 | Dopamine D3 antagonist | |||
| 0.044 | 0.03 | 0.044 | Stearoyl-CoA desaturase inhibitor | |||
| 0.051 | 0.037 | 0.051 | Carbonic anhydrase XII inhibitor | |||
| 0.036 | 0.022 | 0.036 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.07 | 0.056 | 0.07 | Vanilloid antagonist | |||
| 0.07 | 0.057 | 0.07 | CDC25A inhibitor | |||
| 0.061 | 0.047 | 0.061 | Histone deacetylase SIRT3 inhibitor | |||
| 0.056 | 0.043 | 0.056 | Cathepsin L inhibitor | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.034 | 0.02 | 0.034 | Bradykinin B2 receptor antagonist | |||
| 0.05 | 0.037 | 0.05 | Factor IXa inhibitor | |||
| 0.018 | 0.005 | 0.018 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.033 | 0.02 | 0.033 | Vanilloid 4 antagonist | |||
| 0.031 | 0.018 | 0.037 | Liver X receptor alpha antagonist | 0.037 0.011 CID_66 | CID_66 | |
| 0.026 | 0.013 | 0.026 | 5 Hydroxytryptamine 4 agonist | |||
| 0.023 | 0.01 | 0.023 | Factor XIII inhibitor | |||
| 0.022 | 0.01 | 0.022 | Histamine H4 receptor agonist | |||
| 0.037 | 0.024 | 0.037 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.017 | 0.004 | 0.017 | Corticotropin releasing factor antagonist | |||
| 0.089 | 0.077 | 0.089 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.046 | 0.034 | 0.046 | Melanocortin antagonist | |||
| 0.02 | 0.008 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.09 | 0.078 | 0.09 | Insulin receptor antagonist | |||
| 0.153 | 0.141 | 0.153 | MAP kinase kinase 5 inhibitor | |||
| 0.026 | 0.014 | 0.026 | Prostaglandin E2 agonist | 0.025 0.014 CID_66 | ||
| 0.061 | 0.049 | 0.061 | Leukotriene antagonist | |||
| 0.071 | 0.059 | 0.071 | Glutamate (mGluR) antagonist | |||
| 0.015 | 0.003 | 0.015 | Free fatty acid receptor 2 antagonist | |||
| 0.026 | 0.015 | 0.026 | Dopamine autoreceptor agonist | |||
| 0.145 | 0.134 | 0.145 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.057 | 0.045 | 0.057 | Cyclin A1 inhibitor | |||
| 0.038 | 0.027 | 0.038 | Retinoid X receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | Cathepsin L1 inhibitor | |||
| 0.029 | 0.018 | 0.029 | Thrombin receptor antagonist | |||
| 0.041 | 0.03 | 0.057 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.015 CID_66 | CID_66 | |
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.038 | 0.027 | 0.038 | DNA gyrase subunit B inhibitor | |||
| 0.076 | 0.065 | 0.076 | ALK inhibitor | |||
| 0.013 | 0.003 | 0.013 | DNA topoisomerase III inhibitor | 0.008 0.004 CID_66 | ||
| 0.031 | 0.02 | 0.031 | Prostaglandin EP3 antagonist | |||
| 0.032 | 0.022 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 CID_66 | CID_66 | |
| 0.043 | 0.033 | 0.06 | Sphingosine 1-phosphate receptor agonist | 0.06 0.017 CID_66 | CID_66 | |
| 0.047 | 0.037 | 0.047 | HCV NS3/NS4A protease inhibitor | |||
| 0.062 | 0.052 | 0.071 | Beta adrenoreceptor antagonist | 0.071 0.037 CID_66 | CID_66 | |
| 0.018 | 0.008 | 0.018 | NMDA receptor phencyclidine site antagonist | |||
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor antagonist | |||
| 0.042 | 0.033 | 0.042 | Liver X receptor agonist | |||
| 0.036 | 0.027 | 0.036 | 5-Alpha-reductase inhibitor | |||
| 0.039 | 0.031 | 0.039 | Smo receptor antagonist | |||
| 0.015 | 0.006 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 CID_66 | ||
| 0.038 | 0.03 | 0.038 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.018 | 0.01 | 0.018 | Prokineticin receptor 1 antagonist | |||
| 0.036 | 0.028 | 0.036 | Factor XIIIa inhibitor | |||
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | |||
| 0.054 | 0.047 | 0.054 | Prostaglandin EP2 antagonist | |||
| 0.053 | 0.045 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.03 | 0.023 | 0.035 | Liver X receptor antagonist | 0.035 0.017 CID_66 | CID_66 | |
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.029 | 0.022 | 0.029 | Peptide deformylase inhibitor | |||
| 0.039 | 0.032 | 0.039 | Melanocortin 4 antagonist | |||
| 0.052 | 0.045 | 0.066 | Xanthine dehydrogenase inhibitor | 0.066 0.034 CID_66 | CID_66 | |
| 0.044 | 0.037 | 0.05 | Beta adrenoreceptor agonist | 0.05 0.018 CID_66 | CID_66 | |
| 0.022 | 0.015 | 0.022 | Aggrecanase 2 inhibitor | |||
| 0.027 | 0.02 | 0.027 | Glucosylceramidase stimulant | |||
| 0.039 | 0.032 | 0.113 | Estradiol 17 beta-dehydrogenase inhibitor | 0.113 0.009 CID_66 | CID_66 | |
| 0.038 | 0.031 | 0.038 | Erythropoietin receptor agonist | |||
| 0.043 | 0.036 | 0.043 | Glycine transporter 2 inhibitor | |||
| 0.014 | 0.008 | 0.014 | Integrin alphaLbeta2 antagonist | |||
| 0.034 | 0.028 | 0.034 | Orexin receptor 2 antagonist | |||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.077 | 0.071 | 0.077 | Insulin growth factor antagonist | |||
| 0.019 | 0.013 | 0.019 | Antibiotic Anthracycline-like | 0.018 0.016 CID_66 | ||
| 0.015 | 0.01 | 0.015 | Prostaglandin EP4 agonist | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.045 | 0.04 | 0.045 | Transforming growth factor beta 1 antagonist | |||
| 0.032 | 0.028 | 0.032 | Angiotensin II receptor antagonist | |||
| 0.058 | 0.054 | 0.058 | Neutrophil collagenase inhibitor | |||
| 0.02 | 0.016 | 0.02 | Adenosine kinase inhibitor | |||
| 0.067 | 0.063 | 0.067 | Metalloproteinase-9 inhibitor | |||
| 0.02 | 0.016 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.033 | 0.029 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.011 | 0.008 | 0.011 | Melatonin 5 antagonist | |||
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.1 | 0.096 | 0.1 | Cholinergic antagonist | |||
| 0.036 | 0.033 | 0.036 | Histone deacetylase 8 inhibitor | |||
| 0.008 | 0.004 | 0.008 | DNA polymerase III subunit alpha inhibitor | |||
| 0.039 | 0.035 | 0.039 | Leukocyte elastase inhibitor | |||
| 0.034 | 0.031 | 0.034 | Factor X inhibitor | |||
| 0.007 | 0.004 | 0.007 | CC chemokine 6 receptor agonist | |||
| 0.024 | 0.021 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.047 | 0.044 | 0.047 | Antiviral (Hepatitis D) | |||
| 0.034 | 0.031 | 0.034 | Somatostatin 4 agonist | |||
| 0.074 | 0.071 | 0.074 | Insulin like growth factor 1 antagonist | |||
| 0.046 | 0.043 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 CID_66 | ||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.03 | 0.027 | 0.03 | Plasma kallikrein inhibitor | |||
| 0.013 | 0.01 | 0.013 | Cyclin D2 inhibitor | |||
| 0.025 | 0.023 | 0.025 | Cyclin E2 inhibitor | |||
| 0.015 | 0.014 | 0.015 | CDK2/cyclin A3 inhibitor | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.069 | 0.068 | 0.069 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.028 | 0.027 | 0.028 | Vasopressin 1 antagonist | |||
| 0.097 | 0.096 | 0.097 | Acetylcholine antagonist | |||
| 0.035 | 0.034 | 0.038 | Dopamine D3 agonist | 0.038 0.03 CID_66 | CID_66 | |
| 0.03 | 0.029 | 0.03 | Retinoid X receptor agonist | |||
| 0.039 | 0.038 | 0.039 | Factor Xa inhibitor | |||
| 0.03 | 0.029 | 0.03 | Carboxypeptidase B inhibitor | |||
| 0.068 | 0.067 | 0.068 | Phosphodiesterase VI inhibitor | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.087 | 0.086 | 0.087 | Monophenol monooxygenase inhibitor | |||
| 0.007 | 0.009 | 0.015 | Thyroid hormone beta agonist | 0.015 0.004 CID_66 | CID_66 | |
| 0.054 | 0.058 | 0.084 | Dopamine agonist | 0.084 0.035 CID_66 | CID_66 | |
| 0.016 | 0.02 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 CID_66 | CID_66 | |
| 0.059 | 0.064 | 0.078 | Dopamine antagonist | 0.078 0.049 CID_66 | CID_66 | |
| 0.028 | 0.037 | 0.041 | Estrogen-related receptor beta antagonist | 0.041 0.01 CID_66 | CID_66 | |
| 0.015 | 0.024 | 0.054 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.054 0.006 CID_66 | CID_66 | |
| 0.003 | 0.014 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 CID_66 | CID_66 | |
| 0.011 | 0.024 | 0.014 | Integrin beta6 antagonist | 0.014 0.011 CID_66 | CID_66 | |
| 0.047 | 0.06 | 0.059 | Acetylcholine M3 receptor antagonist | 0.059 0.042 CID_66 | CID_66 | |
| 0.023 | 0.042 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.028 CID_66 | CID_66 | |
| 0.011 | 0.038 | 0.038 | Thyroid hormone alpha agonist | 0.038 0.003 CID_66 | CID_66 | |
| 0.219 | 0.249 | 0.268 | Cyclophilin D inhibitor | 0.268 0.193 CID_66 | CID_66 | |
| 0.081 | 0.111 | 0.181 | c-Src kinase inhibitor | 0.181 0.041 CID_66 | CID_66 | |
| 0.024 | 0.058 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.017 CID_66 | CID_66 | |
| 0.097 | 0.134 | 0.143 | Src kinase inhibitor | 0.143 0.088 CID_66 | CID_66 | |
| 0.008 | 0.045 | 0.014 | Somatostatin 2 agonist | 0.014 0.01 CID_66 | CID_66 | |
| 0.093 | 0.133 | 0.262 | Interleukin 4 antagonist | 0.262 0.012 CID_66 | CID_66 | |
| 0.02 | 0.066 | 0.086 | Dopamine D5 antagonist | 0.086 0.011 CID_66 | CID_66 | |
| 0.007 | 0.062 | 0.211 | Estrogen receptor alpha agonist | 0.211 0.004 CID_66 | CID_66 | |
| 0.064 | 0.141 | 0.395 | Estrogen receptor beta antagonist | 0.395 0.004 CID_66 | CID_66 | |
| 0.053 | 0.136 | 0.097 | 5-Lipoxygenase inhibitor | 0.097 0.066 CID_66 | CID_66 | |
| 0.006 | 0.099 | 0.031 | Thyroid hormone alpha antagonist | 0.031 0.005 CID_66 | CID_66 | |
| 0.024 | 0.122 | 0.059 | Raf kinase C inhibitor | 0.059 0.043 CID_66 | CID_66 | |
| 0.054 | 0.156 | 0.121 | Uric acid excretion stimulant | 0.121 0.037 CID_66 | CID_66 | |
| 0.01 | 0.113 | 0.191 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.191 0.004 CID_66 | CID_66 | |
| 0.042 | 0.152 | 0.097 | HIV-1 integrase inhibitor | 0.097 0.026 CID_66 | CID_66 | |
| 0.067 | 0.195 | 0.361 | Estrogen antagonist | 0.361 0.005 CID_66 | CID_66 | |
| 0.011 | 0.147 | 0.048 | Catechol O-methyltransferase inhibitor | 0.048 0.009 CID_66 | CID_66 | |
| 0.129 | 0.266 | 0.164 | Peptidyltransferase inhibitor | 0.164 0.16 CID_66 | CID_66 | |
| 0.025 | 0.17 | 0.065 | Raf kinase inhibitor | 0.065 0.06 CID_66 | CID_66 | |
| 0.065 | 0.215 | 0.105 | Folate antagonist | 0.105 0.057 CID_66 | CID_66 | |
| 0.004 | 0.158 | 0.205 | Estrogen receptor beta agonist | 0.205 0.005 CID_66 | CID_66 | |
| 0.019 | 0.174 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_66 | CID_66 | |
| 0.023 | 0.186 | 0.061 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 CID_66 | CID_66 | |
| 0.049 | 0.219 | 0.096 | DNA polymerase I inhibitor | 0.096 0.091 CID_66 | CID_66 | |
| 0.052 | 0.239 | 0.11 | Vanilloid agonist | 0.11 0.024 CID_66 | CID_66 | |
| 0.008 | 0.196 | 0.213 | Estrogen agonist | 0.213 0.007 CID_66 | CID_66 | |
| 0.006 | 0.23 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_66 | CID_66 | |
| 0.039 | 0.306 | 0.143 | Protein-tyrosine phosphatase inhibitor | 0.143 0.087 CID_66 | CID_66 | |
| 0.015 | 0.294 | 0.078 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.078 0.055 CID_66 | CID_66 | |
| 0.004 | 0.339 | 0.103 | Sphingosine 1-phosphate receptor 3 agonist | 0.103 0.006 CID_66 | CID_66 | |
| 0.064 | 0.423 | 0.246 | Immunosuppressant | 0.246 0.151 CID_66 | CID_66 | |
| 0.036 | 0.455 | 0.172 | Free radical scavenger | 0.172 0.122 CID_66 | CID_66 | |
| 0.005 | 0.433 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 CID_66 | CID_66 | |
| 0.02 | 0.621 | 0.192 | Antioxidant | 0.192 0.12 CID_66 | CID_66 | |
| 0.027 | 0.658 | 0.096 | Transcription factor NF kappa B stimulant | 0.096 0.043 CID_66 | CID_66 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |